Hpv / Projects

3rd Health Programme (2014-2020)
Cancer Leagues Collaborating in Cancer Prevention and Control at the EU and National Level [ECL OG 2014]
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in the EU and non-EU countries at the national le...
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in the EU and non-EU countries at the national level, leagues are often the main resource for the public for cancer control information and services. The running of ECL is financed by fees from its members, which cover a skeleton staff and office expenses. ECL finds it increasingly difficult to run the office on only membership fees, rates which have not changed for 10 years, but due to times of austerity, ECL is unable to justify increasing the fees. Therefore, ECL is applying for this Operating Grant to increase its resources in order to be able to implement actions efficiently in line with its renewed strategy 2014-2017, in particular in its implementation of work for Strategic Goal 2: Promote Cancer Prevention. Cancer prevention actions, including communication campaigns for the public, remain a top priority for ECL and its member leagues, where we have been instrumental in communicating and interpreting for the public the past decade the 3rd Revision of the European Code Against Cancer. With great experience at the national and EU levels, and with proven trust of the public in the Member States, ECL and its member leagues are therefore a natural partner in communicating and disseminating the new (4th) revision of the Code. An EU Grant would be shared with the national leagues to further the other strategic goals: encouraging access to cancer screening; ensuring access to treatment and support; supporting national cancer control programmes and cancer registries; and influencing cancer control policies. More resources would also allow ECL to optimally utilize its network of partners at the European and global level, which include international organisations, the European Parliament, national departments of health etc. to support cancer control in line with priorities of the EU.
Start date: 01/01/2015 - End date: 31/12/2015

Call: Specific Grant Agreements for 2015 under the Framework Partnership Agreement for Operating Grants 2015-2017
Topic: Hpv
3rd Health Programme (2014-2020)
EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016]
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four o...
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four objectives of the Third Health Programme. EPHA has formally reviewed our Strategic Plan 2011-2015. We undertook a thorough consultation process involving Board members, Staff and the EPHA membership, and an analysis of EPHA’s operating environment, strengths and weaknesses. The EPHA membership formally approved the new Strategic Plan 2016-2020 at the Annual General Assembly on 4th September 2015. The Work Programme for 2016 reflects the revised strategy to define a clearer selection of priorities. This approach will enable EPHA to manage activities more effectively, encourage closer cooperation between members and across themes, and better monitor and evaluate our impact.EPHA’s overarching strategic objective remains: “To promote good health and wellbeing, to reduce disease and health inequalities in European policies and programmes”. Priorities selected are as follows:Under Aims 1 and 2 of the 3rdHP and EPHA Strategic Objective “Securing a Governance for Health Approach in Key EU Policies” (HiAP):- Agriculture and Food Policy including Alcohol, Tobacco and NCDs- EU Semester for Health- Healthy Trade Policy- Public Health and Research in the EU BudgetUnder Aims 3 and 4 of the 3rdHP and EPHA Strategic Objective “Strengthen EU Policies to Reduce Health Inequalities and Ensure Universal Access to Sustainable, Inclusive Health Systems”:- Universal and Fair Access to Medicines- Action on Antimicrobial Resistance- Inclusive E- and M-Health- HSPAEach of these areas has operational objectives, milestones, deliverables and impact indicators. The Work Programme 2016 also highlights organisational development objectives, particularly on cooperation with academia, communications and financial sustainability, which are priorities for 2016.
Start date: 01/01/2016 - End date: 31/12/2016
Keywords : [ Amr ] [ Anthrax ] [ Anthrax ] [ Blood ] [ Botulism ] [ Breast ] [ Brucellosis ] [ Campylobacteriosis ] [ Cancer ] [ Cardiovascular Diseases ] [ Cervical ] [ Chlamydia ] [ Cholera ] [ Chronic Diseases ] [ Chronic Diseases ] [ Chronic kidney diseases ] [ Chronic pulmonary diseases ] [ Colorectal ] [ Communicable Diseases ] [ Communicable Diseases ] [ Cryptosporidiosis ] [ Dengue fever ] [ Diabetes ] [ Diphtheria ] [ Diseases of zoonotic and environmental origin and vector borne ] [ E ] [ E/M-Health ] [ Echinococcosis ] [ Economic Policy ] [ Emergent pathogens ] [ Epilepsy ] [ Food and waterborne diseases ] [ Giardisasis ] [ Gonorrhea ] [ HIV, STIs & Blood borne infections ] [ Health Research ] [ Healthcare-associated infections ] [ Hepatitis A ] [ Hepatitis B ] [ Hepatitis C ] [ Hiap ] [ Hiv/Aids ] [ Hpv ] [ Hspa ] [ Hspa. ] [ Influenza ] [ Invasive Haemophilus influenzae disease ] [ Invasive pneumococcal disease ] [ Ischaemic heart disease ] [ Legionnaire's diseaese ] [ Leptospirosis ] [ Leptospirosis ] [ Listeriosis ] [ Lung ] [ M-Health ] [ Malaria ] [ Measles ] [ Menongoccal disease ] [ Multiple sclerosis ] [ Mumps ] [ Musculo skeletal conditions ] [ Ncds ] [ Neurological diseases and disorders ] [ Other specific diseases ] [ Parkinson's disease ] [ Participation ] [ Plague ] [ Polio ] [ Prevention ] [ Prevention ] [ Promotion ] [ Protection ] [ Public Health ] [ Qfever ] [ Rabies ] [ Respiratory tract infections ] [ Rubella ] [ SARS ] [ Salmonellosis ] [ Shigellosis ] [ Shigellosis ] [ Smallpox ] [ Stomach ] [ Stroke ] [ Syphilis ] [ Tetanus ] [ Toxoplasmosis ] [ Trade ] [ Trichinellosis ] [ Tuberculosis ] [ Tularaemia ] [ Tularemia ] [ Type I ] [ Typhoid fever ] [ Universal Access ] [ VTEC ] [ Vaccine-preventable diseases ] [ Variant Creutzfeld-Jakob disease ] [ Viral Haemorrhagic fevers ] [ West Nile fever ] [ Yellow fever ] [ Yersiniosis ] [ campylobacteriosis ] [ pertussis ] [ prostate ] [ salmonellosis ] [ skin ] [ type II ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Hpv
3rd Health Programme (2014-2020)
Cancer Leagues Collaborating in Cancer Prevention and Control at the National and European Level [ECL SGA 2016]
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in the EU and non-EU countries at the national lev...
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in the EU and non-EU countries at the national level, leagues are often the main resource for the public for cancer control information and services. ECL provides a unique platform for cancer leagues to share specific know-how and experiences and is the only network in existence exclusively for cancer leagues. The running of ECL has been mainly financed by fees from its members, which cover a skeleton staff and office expenses. Prior to receiving co-funding in 2015 in the form of an Operating Grant from the EU, ECL's main source of income was membership fees, rates which have not changed for 10 years, but due to times of austerity, ECL has been unable to justify increasing the fees. ECL applied for an Operating Grant in 2014 to increase its resources in order to be able to implement actions efficiently in line with its renewed strategy 2014-2017. In 2015, the EU co-funding allowed us to increase our activities in the implementation of work for Strategic Goal 2: Promote Cancer Prevention. The grant has enabled ECL to increase our work in cancer prevention, and specifically in communicating the new 4th revision of the European Code Against Cancer in 2015, activities which included confirming translations of the Code, encouraging our members to communicate the Code, targeting young adults and incorporating the messages in all our activities including work at the European Parliament. In 2016 we will continue and expand these efforts with the Code as well as continue our normal and important activities such as tobacco control and patient support, while increasing our work at the national levels with our member leagues and other partners, which will include to a limited extent global partners during the World Cancer Congress in October 2016 in Paris.
Start date: 01/01/2016 - End date: 31/12/2016

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Hpv
3rd Health Programme (2014-2020)
Cancer Leagues Collaborating in Cancer Prevention and Control at the National andEuropean Level [ECL SGA 2017]
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in EU and non-EU countries, cancer leagues are the...
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in EU and non-EU countries, cancer leagues are the main resource for the public for cancer control information and services. As the only network exclusively for cancer leagues, ECL provides a unique platform for cancer leagues to share knowledge and experience. Prior to receiving operational grant funding, the running of ECL had been financed mainly by membership fees. The addition of EU co-financing since 2015 has allowed ECL to implement activities more effectively in line with our multi-annual strategy, leading to the progressive increase in activities across all 5 of our strategic goals, providing considerable EU added-value in the process. EU co-funding has enabled ECL to increase our work in cancer prevention, especially the promotion of the European Code Against Cancer (ECAC). This has led to the design of new communication tools to raise awareness amongst the general public; the creation of a youth ambassadors programme to improve dissemination amongst young people; and enhanced networking opportunities for leagues allowing them to share best practice and collaborate more efficiently. In 2017, ECL will continue to disseminate the ECAC, making efforts to measure and assess the impact of these activities. ECL will increase efforts to have explicit references to the ECAC in updated National Cancer Control Plans, and will place greater emphasis on the role of cancer leagues in promoting organised cancer screening programmes. ECL will continue its leading role in tobacco control by supporting the 2017 European Conference on Tobacco or Health (ECToH). ECL shall also launch a new task force on the crucial issue of equal access to medicines. This will complement ECL's ongoing secretariat work on behalf of the MEPs Against Cancer interest group of the European Parliament, and the Patient Support Working Group of ECL.
Start date: 01/01/2017 - End date: 31/12/2017

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)
Topic: Hpv
3rd Health Programme (2014-2020)
Cancer Leagues Collaborating in Cancer Prevention and Control at the EU and National Level [ECL OG 2014]
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in the EU and non-EU countries at the national le...
The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in the EU and non-EU countries at the national level, leagues are often the main resource for the public for cancer control information and services. The running of ECL is financed by fees from its members, which cover a skeleton staff and office expenses. ECL finds it increasingly difficult to run the office on only membership fees, rates which have not changed for 10 years, but due to times of austerity, ECL is unable to justify increasing the fees. Therefore, ECL is applying for this Operating Grant to increase its resources in order to be able to implement actions efficiently in line with its renewed strategy 2014-2017, in particular in its implementation of work for Strategic Goal 2: Promote Cancer Prevention. Cancer prevention actions, including communication campaigns for the public, remain a top priority for ECL and its member leagues, where we have been instrumental in communicating and interpreting for the public the past decade the 3rd Revision of the European Code Against Cancer. With great experience at the national and EU levels, and with proven trust of the public in the Member States, ECL and its member leagues are therefore a natural partner in communicating and disseminating the new (4th) revision of the Code. An EU Grant would be shared with the national leagues to further the other strategic goals: encouraging access to cancer screening; ensuring access to treatment and support; supporting national cancer control programmes and cancer registries; and influencing cancer control policies. More resources would also allow ECL to optimally utilize its network of partners at the European and global level, which include international organisations, the European Parliament, national departments of health etc. to support cancer control in line with priorities of the EU.
Start date: 23/12/2014 - End date: 22/12/2017

Call: Call for Proposals for Framework Partnership Agreement for Operating Grants 2014
Topic: Hpv